About Nanotein Technologies
Nanotein Technologies is a company based in Berkeley (United States) founded in 2019 by Greg Hura and Curtis D Hodge.. Nanotein Technologies offers products and services including NanoSpark TM STEM-T Soluble T Cell Activator, NanoSpark TM EVEN-T Soluble T Cell Activator, and NanoSpark TM GROW-NK Soluble Activator. Nanotein Technologies operates in a competitive market with competitors including Senti Biosciences, Caribou Biosciences, Poseida Therapeutics, Immunocore and Juno Therapeutics, among others.
- Headquarter Berkeley, United States
- Founders Greg Hura, Curtis D Hodge
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanotein Technologies
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanotein Technologies
Nanotein Technologies offers a comprehensive portfolio of products and services, including NanoSpark TM STEM-T Soluble T Cell Activator, NanoSpark TM EVEN-T Soluble T Cell Activator, and NanoSpark TM GROW-NK Soluble Activator. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Activates and expands CAR-T cells for enhanced immunotherapy efficacy.
Controls CD8+ and CD4+ T cell ratios for therapy optimization.
Facilitates feeder-free NK cell activation and expansion for therapies.
Funding Insights of Nanotein Technologies
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series A - Nanotein Technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Nanotein Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nanotein Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanotein Technologies Comparisons
Competitors of Nanotein Technologies
Nanotein Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Caribou Biosciences, Poseida Therapeutics, Immunocore and Juno Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanotein Technologies
Frequently Asked Questions about Nanotein Technologies
When was Nanotein Technologies founded?
Nanotein Technologies was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Where is Nanotein Technologies located?
Nanotein Technologies is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Who is the current CEO of Nanotein Technologies?
Curtis D Hodge is the current CEO of Nanotein Technologies. They have also founded this company.
What does Nanotein Technologies do?
Nanotein Technologies was founded in 2019 in Berkeley, United States, within the biotechnology sector. CAR-T cell therapies are developed by the company to address cancer. Operations include the provision of reagent kits such as the NanoSpark STEM-T Soluble T cell activator, EVEN-T Soluble T Cell Activator, and GROW-NK Soluble Activator, which support T-cell expansion and activation for targeting cancer cells.
Who are the top competitors of Nanotein Technologies?
Nanotein Technologies's top competitors include Immunocore, Juno Therapeutics and Lyell Immunopharma.
What products or services does Nanotein Technologies offer?
Nanotein Technologies offers NanoSpark TM STEM-T Soluble T Cell Activator, NanoSpark TM EVEN-T Soluble T Cell Activator, and NanoSpark TM GROW-NK Soluble Activator.